Healthcare
In an exclusive interview with BioPharma APAC, Professor Ooi Eng Eong, a leading expert in Emerging Infectious Diseases at Duke-NUS Medical School,...
August 22, 2024 | Interview
Collaboration to improve patient care and epidemiological monitoring in Parkway Group's private hospitals QIAstat-Dx syndromic testing to pr...
August 21, 2024 | News
well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...
August 21, 2024 | News
well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...
August 20, 2024 | News
In an exclusive interview with BioPharma APAC, Rehan Saghir, Executive Vice President of ZP Therapeutics, Zuellig Pharma shares his expert insights...
August 20, 2024 | News
Alafia Ai, Inc. (“ALAFIA”) is excited to announce the general availability of AIVAS, an all-in-one interactive high-performance...
August 19, 2024 | News
Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling, announced the completion of enrollment ...
August 16, 2024 | News
Docquity, a leading health tech company established in 2015, is proud to announce its expansion into the B2G sector with the launch of the Puskesmas AI pla...
August 12, 2024 | News
Genova Diagnostics, a global leader in clinical laboratory services, proudly announces the launch of its groundbreaking Alzheimer's Assessment, a non...
August 12, 2024 | News
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Guangdong JiAnTeBo Biotechnology Co., Ltd. (hereinafter r...
August 08, 2024 | News
Docquity, Southeast Asia's largest healthcare professional (HCP) community, has increased Thailand’s demand for duo probiotics from international pha...
August 07, 2024 | News
META Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to its investiga...
August 06, 2024 | News
DKSH Business Unit Healthcare, a Strategic Healthcare Solutions Partner and leading provider of Market Expansion Services for pharmaceutical, over-the-coun...
August 05, 2024 | News
The New Drug Application (NDA) includes data from the Phase III studies OASIS 1, 2 and 3 - showing elinzanetant significantly reduced the frequency...
August 02, 2024 | News
Most Read
Bio Jobs
News
Editor Picks